Lavipharm S.A (LAVI) — Cash Flow Reinvestment Rate

Latest as of December 2022: 33.32x

Lavipharm S.A (LAVI) has a Cash Flow Reinvestment Rate of 33.32x as of December 2022, reinvesting €17.56 Million (capex €17.56 Million ) from operating cash flow of €527.00K. Check cash flow quality index of Lavipharm S.A to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

33.32x
(Capex + Investments) / Operating CF

Total Reinvested

€17.56 Million
Capex + Investments

Operating Cash Flow

€527.00K
EUR

Capital Expenditures

€17.56 Million
EUR

Lavipharm S.A Cash Flow Reinvestment Rate (2014–2024)

Historical reinvestment intensity for Lavipharm S.A across 11 annual periods. Explore long-term investment intensity of Lavipharm S.A to see how much of total assets are deployed in long-term investments.

Annual Cash Flow Reinvestment Rate for Lavipharm S.A (2014–2024)

Year-by-year capital reinvestment analysis for Lavipharm S.A. For live market cap and broader valuation context, see how much is Lavipharm S.A worth.

Year Reinvestment Rate Total Reinvested (EUR) Operating CF Capex YoY Change
2024 4.13x €19.14 Million €4.64 Million €9.64 Million ▼ -84.4%
2023 26.43x €7.51 Million €284.00K €4.05 Million ▲ +24.2%
2022 21.28x €71.21 Million €3.35 Million €35.62 Million ▲ +2038.2%
2021 1.00x €3.80 Million €3.82 Million €1.92 Million ▼ -3.8%
2020 1.03x €2.95 Million €2.85 Million €1.48 Million ▲ +23.9%
2019 0.84x €2.42 Million €2.89 Million €2.42 Million ▲ +14.7%
2018 0.73x €1.03 Million €1.42 Million €1.03 Million ▲ +215.0%
2017 0.23x €350.00K €1.51 Million €350.00K ▲ +25.1%
2016 0.18x €112.00K €606.00K €97.00K ▲ +180.1%
2015 0.07x €38.00K €576.00K €23.00K ▼ -87.1%
2014 0.51x €1.22 Million €2.38 Million €1.20 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow